M&A Deal Summary |
|
|---|---|
| Date | 2014-09-19 |
| Target | Applied Medical - Angioscope |
| Sector | Life Science |
| Buyer(s) | LeMaitre Vascular |
| Deal Type | Divestiture |
| Deal Value | 420M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1983 |
| Sector | Medical Products |
| Employees | 651 |
| Revenue | 220M USD (2024) |
LeMaitre Vascular is a provider of devices for the treatment of peripheral vascular disease. LeMaitre Vascular was founded in 1983 and is based in Burlington, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 8 |
| Sector: Life Science M&A | 2 of 4 |
| Type: Divestiture M&A Deals | 3 of 5 |
| Country: United States M&A | 3 of 6 |
| Year: 2014 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-08-28 |
InaVein
Lexington, Massachusetts, United States InaVein LLC is a provider of "TRIVEX". TRIVEX is a system comprised of capital equipment and disposables that enables less invasive removal of varicose veins. In this procedure, an illuminator instrument is inserted through a small incision into the leg, enabling visualization of varicose veins. |
Buy | $3M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-03-18 |
ProCol Vascular Bioprosthesis
United States ProCol Vascular Bioprosthesis is a natural biological graft derived from a bovine mesenteric vein that provides vascular access for end-stage renal disease ("ESRD") hemodialysis patients. It is intended for the creation of a bridge graft for vascular access subsequent to at least one previously failed prosthetic access graft. |
Buy | - |
